Venous Skin Ulcer Treatment Market Size, Share, Analysis, Trends, Growth, Forecasts, 2032

Venous Skin Ulcer Treatment Market Insights

According to a report from Zion Market Research, the global Venous Skin Ulcer Treatment Market was valued at USD 2.66 Billion in 2023 and is projected to hit USD 4.23 Billion by 2032, with a compound annual growth rate (CAGR) of 5.3% during the forecast period 2024-2032. This report explores market strengths, weakness, opportunities, and threats. It also provides valuable insights into the market's growth drivers, challenges, and the future prospects that may emerge in the Venous Skin Ulcer Treatment Market industry over the next decade.

Request Free Sample

Global Venous Skin Ulcer Treatment Market: Overview

The most common etiology of lower extremity ulceration is venous ulcer, also known as stasis ulcer, occurring in about 1% of the population in the United States. Inflammatory processes resulting in platelet aggregation, endothelial injury, leukocyte activation and intracellular edema are potential causes of venous ulcers. Increasing age, obesity, leg injuries, phlebitis, and deep venous thrombosis are the key risk factors for venous ulcer growth.

Venous ulcers are normally irregular, deep, and found over bony prominences when physically examined. In the ulcer base, granulation tissue and fibrin are normally present. The related effects include edema, lower extremity varicosities, lipodermatosclerosis, and venous dermatitis. Typically, venous ulcers are chronic, and open ulcers can remain for weeks to many years. Osteomyelitis, cellulitis and malignant changes are severe complications.

Large ulcer intensity and prolonged period are poor prognostic factors. Leg elevation, dressings, compression therapy, pentoxifylline, and aspirin therapy are evidence-based treatment choices for venous ulcers. For ulcers that are large in size, of extended length, or refractory to conservative measures, surgical management may be considered.

Request Free Sample

Global Venous Skin Ulcer Treatment Market: Growth Factors

The main factors involved in the development of venous leg ulcers are immobility, obesity, varicose veins, pregnancy, and past deep vein thrombosis. As a consequence, the prevalence of venous leg ulcers is increasingly growing. It is projected that an increase in incidence of venous leg ulcers will improve the global demand for venous skin ulcer treatment. For example, the occurrence of venous leg ulcers in the United States is about 600,000 yearly, as per an article published by the National Center for Biotechnology Information (NCBI). The increase in the geriatric population and the rise in the adoption of advanced wound dressings are also primary factors driving the demand for venous skin ulcer treatment.

The availability of various skin treatments and the increase in patient awareness and healthcare spending are important factors that further drive the global demand for venous skin ulcer treatment.

Impact due to the outbreak of COVID-19

Community service organizations took initiative to offer solutions for the treatment of venous skin ulcers in the midst of the coronavirus (COVID-19) pandemic. For example, the Tissue Viability Society, one of the UK's oldest community service organizations, has taken the steps to provide alternatives for venous skin ulcer treatment in the midst of the coronavirus epidemic by providing its official website with the relevant data on leg ulcer care. Increasing awareness of compression therapy products is accelerating revenue generation strategies for companies in the venous skin ulcer treatment market.

Since patients are seeking care for leg ulcer at home in the midst of the pandemic, companies in the treatment market for venous skin ulcer should improve their online sales and home delivery services to fulfill specific requirements for patients. The revenue from home care settings is therefore expected to rise rapidly in demand for the treatment of venous skin ulcers.

Global Venous Skin Ulcer Treatment Market: Segmentation

Compression therapy plays a crucial role in the prevention and recurrence of lower leg ulceration. There is, however, a lack of clear understanding of the preference of compression hosiery products to minimize venous skin ulcer recurrence. As a result, companies in the venous skin ulcer treatment industry are urging healthcare professionals to establish health programs that educate patients about the therapeutic benefits of compression hosiery products.

High rates of infection after healing have fueled the need for compression hosiery products in the venous skin ulcer treatment industry. This is obvious as the revenue from compression therapy products is expected to increase dramatically in the demand for venous skin ulcer treatment.

Improving skills of nursing workers results in improved uptake of wound dressings. For instance, community nursing teams are growing their emphasis in the Midlands, U.K., on managing venous leg ulcers effectively. Stakeholders who are part of the Midlands Partnership NHS Foundation Trust, for example, are providing a wide range of standardized evaluations by implementing the lower-limb evaluation algorithm for the treatment of venous skin ulcers.

Venous Skin Ulcer Treatment Market: Report Scope

Global Venous Skin Ulcer Treatment Market: Regional Analysis

By Geography, the venous skin ulcer treatment market is segmented into North America, Europe, Latin America, Asia Pacific, and Middle East and Africa.

North America dominated the global market for venous skin ulcer treatment in 2019 due to the rising prevalence of chronic wounds, a better reimbursement scenario, and early acceptance of advanced products in the region. For example, according to Centers for Disease Control and Prevention (CDC) report, about 2.5 million patients in the U.S. struggle from pressure ulcers every year.

The market in Asia Pacific is expected to expand at a significant CAGR during the forecast period due to a rise in the geriatric population, the advent of strong local manufacturers providing technologically advanced products at lower prices, and an increase in public awareness of early treatment of chronic wounds.

Global Venous Skin Ulcer Treatment Market: Competitive Players

The major players in the global venous skin ulcer treatment market include

• Integra LifeSciences Corporation
• Smith & Nephew plc.
• Mölnlycke Health Care AB
• 3M
• Cardinal Health
• URGO Medical
• PAUL HARTMANN AG
• Bauerfeind
• SIGVARIS

The Report segment of global venous skin ulcer treatment market are as follows:

By Type 

• Conservative Management
• Mechanical Treatment
• Surgical Management
• Medications
• Others

By End User 

• Hospital & Clinics
• Home Care Settings
• Long-Term Care Facilities
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa